Industry NewsBARDA and Luminex Corporation enter into a public-private partnership to develop an advanced serology test for use during the COVID-19 pandemic
Product NewsLuminex Corporation Receives FDA Emergency Use Authorization for Zika Virus Molecular Detection Assay
Product NewsLuminex Corporation Receives FDA Clearance for New Molecular Test for Identification and Differentiation of Influenza A/B and Respiratory Syncytial Virus
Editorial ArticleDevelopment of a Luminex xMAP® Assay to Detect Amyloid β Oligomers in Alzheimer’s Disease Cerebrospinal Fluid
Product NewsLuminex® Corporation Launches the NxTAG™ Respiratory Pathogen Panel (RUO) - A Closed-Tube, Flexibly Scalable Solution for Respiratory Testing
Product NewsLuminex Receives FDA Clearance to Add New Clinical Targets and Additional Sample Type for Use with xTAG® Gastrointestinal Pathogen Panel
Product NewsLuminex Corporation Announces European Unveiling of its New Sample-to-Answer System at ECCMID
Product NewsLuminex Corporation Receives FDA and European Clearance for a New Personalized Medicine Genotyping Assay
Product NewsLuminex Corporation and EMD Millipore Extend Their Global Supply and Distribution Agreement
Product NewsLuminex Corporation Receives U.S. FDA Clearance for MAGPIX® Instrument with Novel xTAG® Gastrointestinal Pathogen Panel
Product NewsMerck and Luminex Corporation Collaborate to Develop Companion Diagnostic Device to Support Investigational BACE inhibitor Clinical Development Program for Alzheimer’s Disease
Product NewsLuminex Receives FDA Clearance for First Comprehensive Gastrointestinal Pathogen Infectious Disease Diagnostic in the United States
